Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DHC
DHC logo

DHC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.210
Open
7.120
VWAP
6.88
Vol
11.61M
Mkt Cap
714.69M
Low
6.710
Amount
79.85M
EV/EBITDA(TTM)
--
Total Shares
--
EV
3.37B
EV/OCF(TTM)
41.91
P/S(TTM)
0.57
Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
Show More

Events Timeline

(ET)
2025-09-03
08:18:12
AlerisLife Sells 116 Management Agreements, Reports Diversified Healthcare Trust
select
2025-05-05 (ET)
2025-05-05
16:28:15
Diversified Healthcare Trust reports Q1 normalized FFO 6c, consensus 4c
select
2025-02-25 (ET)
2025-02-25
16:25:16
Diversified Healthcare Trust reports Q4 normalized FFO 2c vs. 3c last year
select

News

Fool
2.0
03-07Fool
Flat Footed LLC Fully Liquidates Matson Stake
  • Stake Liquidation: Flat Footed LLC fully liquidated its 314,076-share stake in Matson during Q4 2026, resulting in a $30.96 million decrease in the position's quarter-end value, highlighting the impact of market fluctuations on its investment portfolio.
  • Market Performance: As of February 17, 2026, Matson's shares were priced at $165.05, reflecting a 12.1% increase over the past year, outperforming the S&P 500 by 2.27 percentage points, indicating its relative strength in the shipping industry.
  • Financial Overview: Matson's latest financial metrics reveal a TTM revenue of $3.34 billion and a net income of $444.8 million, with a dividend yield of 0.91%, suggesting a solid revenue stream and profitability.
  • Industry Outlook: While global freight markets stabilize, Matson must focus on cargo demand in its domestic trade lanes and customers' willingness to pay for expedited shipping services to sustain profitability and competitive positioning.
NASDAQ.COM
2.0
03-07NASDAQ.COM
Flat Footed LLC Fully Liquidates Matson Stake
  • Position Liquidation: Flat Footed LLC sold its entire stake of 314,076 shares in Matson during Q4, resulting in an estimated trade size of $30.96 million, which led to a 3.4% decrease in its reported AUM.
  • Market Dynamics Impact: This transaction reflects not only the liquidation of Flat Footed LLC's holdings but also the impact of Matson's stock price fluctuations, resulting in a quarter-end position value of zero, down from 3.8% of the fund's AUM in the previous quarter.
  • Industry Competitiveness: Matson, a leading provider of ocean transportation and logistics services, focuses on domestic U.S. trade lanes, particularly in Hawaii, Alaska, and Guam, benefiting from the protection of the Jones Act, which limits foreign competition.
  • Future Outlook: While Matson benefited from strong trans-Pacific demand and premium pricing during the pandemic, its profitability will depend on continued cargo demand in domestic trade lanes and customers' willingness to pay for expedited shipping as global freight markets stabilize.
NASDAQ.COM
8.5
03-05NASDAQ.COM
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
  • Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
  • Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
  • Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
  • Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
Fool
8.5
03-05Fool
BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares
  • Share Increase: According to a recent SEC filing dated February 17, 2026, BlackBarn Capital Partners LP acquired an additional 2 million shares of Warby Parker, raising its total stake to 3 million shares, with an estimated transaction value of $43.52 million, reflecting confidence in the company's growth potential.
  • Asset Management Proportion: Warby Parker now accounts for 4.3% of BlackBarn Capital's reportable assets under management, indicating its significance in the firm's 13F report and investor recognition of its potential value.
  • Market Performance: As of February 13, 2026, Warby Parker shares were priced at $22.46, down 15% over the past year and underperforming the S&P 500 by 26.8 percentage points, highlighting market concerns regarding its future growth.
  • Business Model Analysis: Warby Parker challenges traditional eyewear retail economics through a direct-to-consumer model, and while facing high costs and competitive pressures, its expanding exam capacity may ultimately be key to its future profitability.
seekingalpha
9.5
02-24seekingalpha
Diversified Healthcare Trust Q4 2025 Earnings Call Highlights
  • Capital Markets Activity: DHC successfully executed capital markets activities in 2025, exceeding $1.4 billion in financing and asset sales while establishing a $150 million undrawn credit facility, significantly enhancing the company's financial flexibility and competitive position in the market.
  • Strong Operational Performance: The company reported a 31.3% growth in SHOP NOI for 2025, with Q4 showing a year-over-year increase of 27.6% to $38.3 million, demonstrating robust operational efficiency and demand, solidifying its leading position in the U.S. REIT market.
  • Asset Dispositions and Leverage Reduction: DHC disposed of 69 properties in 2025 for $605 million, successfully reducing the net debt to adjusted EBITDA ratio from 11.2x to 8.1x, thereby enhancing the company's financial health and stability.
  • Positive Future Outlook: Management projects 2026 SHOP NOI to range from $175 million to $185 million and adjusted EBITDA to be between $290 million and $305 million, indicating strong growth potential driven by ongoing investments and operational improvements.
NASDAQ.COM
9.5
02-24NASDAQ.COM
Diversified Healthcare Reports Missed FFO Estimates
  • Quarterly FFO Performance: Diversified Healthcare reported FFO of $0.09 per share, missing the Zacks consensus estimate of $0.12, indicating a 25% negative surprise that highlights pressure on the company's profitability.
  • Revenue Situation: The company posted revenues of $379.57 million for the quarter, falling short of the Zacks consensus estimate by 4.53%, and nearly matching last year's $379.62 million, suggesting a lack of significant improvement in market demand.
  • Market Performance: Although Diversified Healthcare's stock has risen about 28.7% since the beginning of the year, significantly outperforming the S&P 500's 0.9% gain, future stock movements will largely depend on management's commentary during the earnings call and FFO outlook.
  • Industry Outlook: The REIT and Equity Trust - Other sector is currently ranked in the bottom 35% of Zacks industries, which could materially impact Diversified Healthcare's stock performance, prompting investors to monitor overall industry trends.
Wall Street analysts forecast DHC stock price to rise
3 Analyst Rating
Wall Street analysts forecast DHC stock price to rise
1 Buy
1 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
3.00
Averages
3.75
High
4.50
Current: 0.000
sliders
Low
3.00
Averages
3.75
High
4.50
B. Riley
John Massocca
Buy
maintain
AI Analysis
2026-03-03
Reason
B. Riley
John Massocca
Price Target
AI Analysis
2026-03-03
maintain
Buy
Reason
B. Riley analyst John Massocca raised the firm's price target on Diversified Healthcare Trust to $8.50 from $6.50 and keeps a Buy rating on the shares. The firm says the company's 2026 outlook is an indicator of its "value growth potential." It sees the stock's discount to peers as "too severe."
B. Riley
John Massocca
Buy
maintain
2025-12-15
Reason
B. Riley
John Massocca
Price Target
2025-12-15
maintain
Buy
Reason
B. Riley analyst John Massocca raised the firm's price target on Diversified Healthcare Trust to $6.50 from $5.50 and keeps a Buy rating on the shares. Despite the recent shift of $25.8M of planned dispositions to 1Q26, the firm remains confident Diversified Healthcare Trust will have ample liquidity to address January zero-coupon debt maturity, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DHC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Diversified Healthcare Trust (DHC.O) is -2.89, compared to its 5-year average forward P/E of -2.90. For a more detailed relative valuation and DCF analysis to assess Diversified Healthcare Trust's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.90
Current PE
-2.89
Overvalued PE
-2.23
Undervalued PE
-3.57

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
13.63
Current EV/EBITDA
14.24
Overvalued EV/EBITDA
14.52
Undervalued EV/EBITDA
12.73

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.40
Current PS
0.38
Overvalued PS
0.46
Undervalued PS
0.34

Financials

AI Analysis
Annual
Quarterly

Whales Holding DHC

S
Silver Point Capital, L.P.
Holding
DHC
-13.06%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Diversified Healthcare Trust (DHC) stock price today?

The current price of DHC is 6.71 USD — it has decreased -6.15

What is Diversified Healthcare Trust (DHC)'s business?

Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.

What is the price predicton of DHC Stock?

Wall Street analysts forecast DHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DHC is3.75 USD with a low forecast of 3.00 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Diversified Healthcare Trust (DHC)'s revenue for the last quarter?

Diversified Healthcare Trust revenue for the last quarter amounts to 386.86M USD, increased 4.34

What is Diversified Healthcare Trust (DHC)'s earnings per share (EPS) for the last quarter?

Diversified Healthcare Trust. EPS for the last quarter amounts to -0.04 USD, decreased -88.89

How many employees does Diversified Healthcare Trust (DHC). have?

Diversified Healthcare Trust (DHC) has 0 emplpoyees as of March 22 2026.

What is Diversified Healthcare Trust (DHC) market cap?

Today DHC has the market capitalization of 714.69M USD.